Skip to main content
Year archive

NEURIZON THERAPEUTICS LIMITED — 2024 filings

All 144 regulatory filings released by NEURIZON THERAPEUTICS LIMITED (NUZ) in 2024, sourced directly from the official regulator.

144 Filings
2024 Period
2024 filings (144)
Filing Released Lang
Application for quotation of securities - NUZ 6 pages 18.3KB
Share Issue/Capital Change
2024-12-26 English
Section 708A Cleansing Statement 2 pages 308.5KB
Capital/Financing Update
2024-12-26 English
Neurizon Files IND Application to Support HEALEY ALS Trial 2 pages 381.4KB
Regulatory Filings
2024-12-17 English
Neurizon Granted OMPD for NUZ-001 in Europe 2 pages 349.3KB
Regulatory Filings
2024-12-16 English
Positive 8-month Interim Data from OLE Study 3 pages 830.2KB
Interim / Quarterly Report FY 2024
2024-12-15 English
Neurizon Presents Company Update and 2025 Outlook 26 pages 2.2MB
Investor Presentation
2024-12-11 English
Neurizon Receives Additional R&D Tax Incentive Rebate 1
Capital/Financing Update
2024-12-10 English
Notice of Company Update Webinar 2 pages 344.1KB
Regulatory Filings
2024-12-04 English
Application for quotation of securities - NUZ 6 pages 18.3KB
Share Issue/Capital Change
2024-11-28 English
Section 708A Cleansing Statement 2 pages 306.7KB
Share Issue/Capital Change
2024-11-28 English
Updated Securities Trading Policy 16 pages 604.6KB
Governance Information
2024-11-18 English
NUZ-001 Reduces Aggregation of Key ALS Disease Target 4 pages 714.7KB
Regulatory Filings
2024-11-14 English
Neurizon Presents Positive Preclinical Data on NUZ-001 24 pages 4.5MB
Investor Presentation
2024-11-14 English
Correction to text positioning error in announcement 6 pages 1.0MB
Regulatory Filings
2024-11-14 English
Positive opinion received on OMPD for NUZ-001 in Europe 2 pages 350.5KB
Regulatory Filings
2024-11-10 English
Change of Director's Interest Notices x4 11 pages 866.2KB
Director's Dealing
2024-11-07 English
Notification regarding unquoted securities - NUZ 6 pages 20.4KB
Share Issue/Capital Change
2024-11-06 English
Notification regarding unquoted securities - NUZ 7 pages 24.9KB
Share Issue/Capital Change
2024-11-06 English
Notification regarding unquoted securities - NUZ 7 pages 23.5KB
Share Issue/Capital Change
2024-11-06 English
Application for quotation of securities - NUZ 6 pages 18.5KB
Share Issue/Capital Change
2024-10-31 English
Application for quotation of securities - NUZ 6 pages 18.9KB
Share Issue/Capital Change
2024-10-31 English
Application for quotation of securities - NUZ 6 pages 18.3KB
Share Issue/Capital Change
2024-10-31 English
Application for quotation of securities - NUZ 6 pages 19.2KB
Share Issue/Capital Change
2024-10-31 English
Section 708A Cleansing Statement 2 pages 242.8KB
Capital/Financing Update
2024-10-31 English
Appendix 4C & Quarterly Update 10 pages 711.4KB
Interim / Quarterly Report Q1 2025
2024-10-30 English
Neurizon Presents Phase 1 MEND Study Data at NEALS Meeting 4 pages 1.4MB
Regulatory Filings
2024-10-24 English
PharmAust changes name to Neurizon Therapeutics 2 pages 351.7KB
Regulatory Filings
2024-10-14 English
PharmAust Receives R&D Tax Incentive Rebate 2 pages 556.9KB
Capital/Financing Update
2024-10-08 English
Chairman's AGM Address 3 pages 606.4KB
AGM Information
2024-10-08 English
AGM Presentation 24 pages 2.9MB
AGM Information
2024-10-08 English
Results of Annual General Meeting 5 pages 746.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-10-08 English
Application for quotation of securities - PAA 6 pages 18.2KB
Capital/Financing Update
2024-09-29 English
Section 708A Cleansing Statement 2 pages 597.1KB
Capital/Financing Update
2024-09-29 English
EMA pre-submission meeting paves the way for OMPD Request 2 pages 296.4KB
Regulatory Filings
2024-09-16 English
Notice of Annual General Meeting/Proxy Form 64 pages 2.0MB
AGM Information
2024-09-04 English
Proposed issue of securities - PAA 6 pages 22.6KB
Capital/Financing Update
2024-09-04 English
Change of AGM Date 2 pages 557.5KB
AGM Information
2024-09-01 English
Application for quotation of securities - PAA 6 pages 18.2KB
Share Issue/Capital Change
2024-09-01 English
Section 708A Cleansing Statement 2 pages 596.8KB
Capital/Financing Update
2024-09-01 English
Appendix 4E and 2024 Annual Report 74 pages 3.1MB
Annual Report FY 2024
2024-08-29 English
Appendix 4G and Corporate Governance Statement 24 pages 948.4KB
Regulatory Filings
2024-08-29 English
Positive Interim Study Results from OLE Study in ALS 5 pages 1.1MB
Interim / Quarterly Report Q3 2024
2024-08-25 English
AGM Date & Director Nominations Closing Date for AGM 2 pages 532.7KB
AGM Information
2024-08-04 English
Application for quotation of securities - PAA 6 pages 18.3KB
Share Issue/Capital Change
2024-07-29 English
Section 708A Cleansing Statement 2 pages 597.3KB
Share Issue/Capital Change
2024-07-29 English
Change of Director's Interest Notices x2 6 pages 631.8KB
Director's Dealing
2024-07-28 English
Appendix 4C & Quarterly Update 10 pages 912.9KB
Interim / Quarterly Report Q4 2024
2024-07-28 English
Application for quotation of securities - PAA 6 pages 18.4KB
Share Issue/Capital Change
2024-07-24 English
PharmAust Completes Share Purchase Plan 3 pages 579.5KB
Capital/Financing Update
2024-07-23 English
Monepantel Selected for Entry into HEALEY ALS Platform Trial 3 pages 583.4KB
Regulatory Filings
2024-07-14 English
Investor Update - HEALEY ALS Platform Trial Selection 21 pages 3.5MB
Investor Presentation
2024-07-14 English
Investor Briefings & Webinar Notice 2 pages 222.4KB
Investor Presentation
2024-07-07 English
PharmAust Granted SME Status by European Medicines Agency 2 pages 598.4KB
Regulatory Filings
2024-06-30 English
Share Purchase Plan Cleansing Notice 2 pages 558.8KB
Capital/Financing Update
2024-06-27 English
Share Purchase Plan Offer Booklet 26 pages 1.2MB
Capital/Financing Update
2024-06-27 English
Application for quotation of securities - PAA 6 pages 18.9KB
Share Issue/Capital Change
2024-06-27 English
Application for quotation of securities - PAA 6 pages 19.3KB
Share Issue/Capital Change
2024-06-27 English
Notification regarding unquoted securities - PAA 6 pages 20.6KB
Share Issue/Capital Change
2024-06-27 English
Section 708A Cleansing Statement 2 pages 600.7KB
Capital/Financing Update
2024-06-27 English
Application for quotation of securities - PAA 5 pages 16.8KB
Share Issue/Capital Change
2024-06-26 English
PharmAust raises $10 million via Placement and announces SPP 4 pages 667.0KB
Capital/Financing Update
2024-06-20 English
Proposed issue of securities - PAA 10 pages 32.7KB
Capital/Financing Update
2024-06-20 English
PharmAust Presentation 19 pages 4.1MB
Investor Presentation
2024-06-20 English
Trading Halt 2 pages 983.2KB
Regulatory Filings
2024-06-18 English
Initial Director's Interest Notice - K.MacFarlane 2 pages 304.6KB
Director's Dealing
2024-06-18 English
PharmAust's Phase 1 Study Data Presented at Major Conference 3 pages 584.3KB
Regulatory Filings
2024-06-17 English
Appointment of Non-Executive Director 2 pages 243.9KB
Board/Management Information
2024-06-16 English
OLE Study update reveals impressive Survival Data 5 pages 1.1MB
Regulatory Filings
2024-06-04 English
Final Director's Interest Notice - J.Clark 2 pages 354.9KB
Director's Dealing
2024-06-03 English
Initial Director's Interest Notice - M.Thurn 2 pages 372.7KB
Director's Dealing
2024-06-03 English
Executive team strengthened, appointment of MD/CEO & new CSO 4 pages 596.6KB
Board/Management Information
2024-05-30 English
Change of Registered Office and Principal Place of Business 2 pages 309.2KB
Regulatory Filings
2024-05-27 English
Appointment of Company Secretary 2 pages 244.8KB
Board/Management Information
2024-05-23 English
PharmAust appoints Sergio Duchini as Non-Executive Chairman 2 pages 227.6KB
Board/Management Information
2024-05-16 English
Final Director's Interest Notice 2 pages 219.5KB
Director's Dealing
2024-05-16 English
Initial Director's Interest Notice 2 pages 147.8KB
Director's Dealing
2024-05-16 English
PharmAust receives Orphan Drug Designation for monepantel 2 pages 223.9KB
Regulatory Filings
2024-05-16 English
Investor Webinar Presentation 13 pages 2.5MB
Investor Presentation
2024-05-16 English
Investor update 3 pages 236.0KB
Board/Management Information
2024-05-13 English
Final Director's Interest Notice 2 pages 247.8KB
Director's Dealing
2024-05-13 English
Initial Director's Interest Notice x 2 4 pages 180.9KB
Director's Dealing
2024-05-09 English
Final Director's Interest Notice X 3 6 pages 312.0KB
Director's Dealing
2024-05-09 English
Board Changes 3 pages 228.6KB
Board/Management Information
2024-05-08 English
Application for quotation of securities - PAA 6 pages 18.3KB
Share Issue/Capital Change
2024-05-08 English
Cleansing Notice 1 page 165.3KB
Share Issue/Capital Change
2024-05-08 English
Trading Halt 2 pages 573.5KB
Regulatory Filings
2024-05-06 English
Appendix 4C & Quarterly Update 11 pages 421.2KB
Interim / Quarterly Report Q3 2024
2024-04-29 English
Resignation of Dr Michael Thurn & appointment of John Clark 2 pages 224.4KB
Board/Management Information
2024-04-22 English
Application for quotation of securities - PAA 6 pages 18.3KB
Share Issue/Capital Change
2024-04-18 English
Cleansing Notice 1 page 165.0KB
Share Issue/Capital Change
2024-04-18 English
PharmAust makes Head of Manufacturing appointment 3 pages 254.8KB
Board/Management Information
2024-04-17 English
Final Ethics Approval for Open-Label MND Extension Study 3 pages 248.3KB
Regulatory Filings
2024-04-09 English
Application for quotation of securities - PAA 6 pages 18.3KB
Share Issue/Capital Change
2024-04-04 English
Cleansing Notice 1 page 164.9KB
Share Issue/Capital Change
2024-04-04 English
Pause in Trading 1 page 118.0KB
Regulatory Filings
2024-04-01 English
Trading Halt 2 pages 205.9KB
Regulatory Filings
2024-04-01 English
Media clarification 2 pages 197.1KB
Regulatory Filings
2024-04-01 English
Application for quotation of securities - PAA 7 pages 21.8KB
Regulatory Filings
2024-03-26 English
Cleansing Notice 1 page 165.3KB
Share Issue/Capital Change
2024-03-26 English
PharmAust to present at NWR Virtual Healthcare Conference 2 pages 201.3KB
Investor Presentation
2024-03-18 English
Positive clinical data filed with FDA to support ODD request 3 pages 201.3KB
Regulatory Filings
2024-03-13 English
Singapore Healthcare Day Presentation 26 pages 4.2MB
Investor Presentation
2024-03-13 English
Application for quotation of securities - PAA 6 pages 18.3KB
Share Issue/Capital Change
2024-03-06 English
Cleansing Notice 1 page 164.8KB
Capital/Financing Update
2024-03-06 English
Appendix 4D & Half-Year Report 24 pages 963.9KB
Interim / Quarterly Report H1 2024
2024-02-28 English
Application for quotation of securities - PAA 7 pages 21.1KB
Share Issue/Capital Change
2024-02-27 English
Cleansing Notice 1 page 164.9KB
Share Issue/Capital Change
2024-02-27 English
Positive Phase 1 MEND Study Top-Line Results 4 pages 296.1KB
Capital/Financing Update
2024-02-26 English
Presentation - Phase 1 Top-Line Results 16 pages 1.5MB
Investor Presentation
2024-02-26 English
Trading Halt 2 pages 578.5KB
Regulatory Filings
2024-02-25 English
Investor webinar - Phase 1 MND Study Top-Line Results 2 pages 197.5KB
Investor Presentation
2024-02-25 English
Application for quotation of securities - PAA 7 pages 21.0KB
Share Issue/Capital Change
2024-02-22 English
Application for quotation of securities - PAA 6 pages 19.2KB
Share Issue/Capital Change
2024-02-22 English
Notification regarding unquoted securities - PAA 6 pages 18.8KB
Share Issue/Capital Change
2024-02-22 English
Change of Director's Interest Notice 2 pages 212.7KB
Director's Dealing
2024-02-22 English
Cleansing Notice 1 page 193.9KB
Share Issue/Capital Change
2024-02-22 English
Results of General Meeting 2 pages 466.2KB
Declaration of Voting Results & Voting Rights Announcements
2024-02-21 English
PharmAust Forms World-Class Scientific Advisory Board 3 pages 213.5KB
Board/Management Information
2024-02-21 English
EGM Shareholder Presentation 17 pages 3.8MB
Investor Presentation
2024-02-20 English
FDA Outlines Pathway to Accelerated Approval for MPL in MND 2 pages 170.0KB
Capital/Financing Update
2024-02-15 English
Extension Study Begins, Analysis Suggests Survival Benefit 3 pages 358.9KB
Regulatory Filings
2024-02-13 English
Application for quotation of securities - PAA 6 pages 19.0KB
Share Issue/Capital Change
2024-02-12 English
Cleansing Notice 1 page 223.7KB
Share Issue/Capital Change
2024-02-12 English
Application for quotation of securities - PAA 6 pages 18.2KB
Share Issue/Capital Change
2024-02-05 English
Cleansing Notice 1 page 223.6KB
Share Issue/Capital Change
2024-02-05 English
Dr Thomas Duthy appointed as Non-Executive Director 2 pages 165.2KB
Board/Management Information
2024-02-04 English
Initial Director's Interest Notice 2 pages 150.9KB
Director's Dealing
2024-02-04 English
Investor Presentation and Non-Deal Roadshow 17 pages 3.0MB
Investor Presentation
2024-02-04 English
Appendix 4C & Quarterly Update 11 pages 371.8KB
Interim / Quarterly Report Q2 2024
2024-01-30 English
Ethics Committee Approval for Open-Label MND Extension Study 2 pages 206.4KB
Regulatory Filings
2024-01-29 English
FDA Provides Clear Feedback for ODD Approval 2 pages 170.3KB
Regulatory Filings
2024-01-28 English
Notification regarding unquoted securities - PAA 8 pages 34.6KB
Share Issue/Capital Change
2024-01-18 English
Notice of General Meeting & Proxy Form 21 pages 616.4KB
Proxy Solicitation & Information Statement
2024-01-18 English
PharmAust Partners with Berry Consultants for MND Phase 2/3 2 pages 173.9KB
Regulatory Filings
2024-01-15 English
Application for quotation of securities - PAA 6 pages 28.4KB
Share Issue/Capital Change
2024-01-04 English
Cleansing Notice 1 page 223.6KB
Share Issue/Capital Change
2024-01-04 English
Appendix 3Y x 3 6 pages 299.9KB
Director's Dealing
2024-01-04 English
Cleansing Prospectus & Target Market Determination 29 pages 541.4KB
Capital/Financing Update
2024-01-01 English
Proposed issue of securities - PAA 6 pages 30.0KB
Capital/Financing Update
2024-01-01 English
Application for quotation of securities - PAA 7 pages 30.6KB
Share Issue/Capital Change
2024-01-01 English
Notification regarding unquoted securities - PAA 7 pages 30.8KB
Share Issue/Capital Change
2024-01-01 English
Cleansing Notice 1 page 223.6KB
Share Issue/Capital Change
2024-01-01 English
Application for quotation of securities - PAA 6 pages 28.4KB
Capital/Financing Update
2024-01-01 English
FDA Grants PharmAust Pre-IND Meeting 2 pages 170.3KB
Regulatory Filings
2024-01-01 English